136 related articles for article (PubMed ID: 6337004)
1. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
[TBL] [Abstract][Full Text] [Related]
2. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
Warrington SJ; Smith PR; O'Grady J
Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
[TBL] [Abstract][Full Text] [Related]
4. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous infusion of prostacyclin (PGI2) in man.
O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).
Orchard MA; Ritter JM; Shepherd GL; Lewis PJ
Br J Clin Pharmacol; 1983 May; 15(5):509-11. PubMed ID: 6344895
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
[No Abstract] [Full Text] [Related]
8. Potentiation of anti-aggregating activity of PGI2 by 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in rabbit platelets in vitro.
Tanaka K; Harada Y; Iwata M; Katori M
Prostaglandins; 1980 Aug; 20(2):255-68. PubMed ID: 6997930
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
Karim SM; Adaikan PG; Lau LC; Tai MY
Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation.
Dembińska-Kièć A; Rücker W; Schönhöfer PS
Atherosclerosis; 1979 Jul; 33(3):315-27. PubMed ID: 226106
[TBL] [Abstract][Full Text] [Related]
11. Epoprostenol (prostacyclin,PGI2) increases apparent liver blood flow in man.
Hassan S; Pickles H
Prostaglandins Leukot Med; 1983 Apr; 10(4):449-54. PubMed ID: 6344102
[TBL] [Abstract][Full Text] [Related]
12. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
[TBL] [Abstract][Full Text] [Related]
13. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
14. Enhanced prostacyclin production by dipyridamole in man.
Neri Serneri GG; Masotti G; Poggesi L; Galanti G; Morettini A
Eur J Clin Pharmacol; 1981; 21(1):9-15. PubMed ID: 7037426
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
Casals-Stenzel J; Buse M; Losert W
Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
[TBL] [Abstract][Full Text] [Related]
17. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
18. Myocardial ischemia induced by prostacyclin and iloprost.
Bugiardini R; Galvani M; Ferrini D; Gridelli C; Tollemeto D; Mari L; Puddu P; Lenzi S
Clin Pharmacol Ther; 1985 Jul; 38(1):101-8. PubMed ID: 2408809
[TBL] [Abstract][Full Text] [Related]
19. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
Mehta J; Mehta P
J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
